Troutman Pepper Hamilton Sanders LLP advised BioXcel LLC on the deal. BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a clinical-stage biopharmaceutical development company, announced the pricing of an...
Troutman Pepper Hamilton Sanders LLP advised BioXcel LLC on the deal. BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a clinical-stage biopharmaceutical development company, announced the pricing of an...
You must be a Standard 1 Year member to access this content.